USPS Priority $10 • UPS 2nd Day Air $15 • USPS Express $30
Allow 7–10 business days before shipment.
Products in this catalog are supplied as research materials only. They are not drugs, foods, cosmetics, supplements, or medical devices and are not intended to diagnose, treat, cure, or prevent disease.
Product specifications, research context, and handling information.
CJC-1295 (No DAC), commonly referred to as Modified GRF (1–29), is a synthetic GHRH analog supplied without a Drug Affinity Complex.
Research examines GHRH receptor activation, pituitary responses, and shorter-duration endocrine signaling relative to DAC-modified analogs. This listing is supplied as a kit of 10 vials, with per-vial amounts shown in Product Details.
The modified GHRH sequence interacts with GHRH receptors. Without the DAC group, it lacks the albumin-conjugating modification used to prolong exposure in CJC-1295 DAC.
The non-DAC form is relevant to studies of shorter-duration GHRH activity and growth hormone release patterns. Comparisons with DAC-modified analogs examine how exposure duration shapes the endocrine response.
This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.
